Want to see CH:YPSN full AI Analyst Report?
YPSN Stock Chart & Stats
CHF307.50
-CHF5.00(-1.41%)
At close: 4:00 PM EST
CHF307.50
-CHF5.00(-1.41%)
Day’s Range― - ―
52-Week RangeCHF260.50 - CHF441.50
Previous CloseN/A
Volume2.70K
Average Volume (3M)17.31K
Market Cap
CHF4.92B
Enterprise ValueCHF4.81B
Total Cash (Recent Filing)CHF28.56M
Total Debt (Recent Filing)CHF260.77M
Price to Earnings (P/E)22.1
Beta0.68
Next Earnings
Nov 18, 2026EPS Estimate
5.25Next Dividend Ex-DateN/A
Dividend Yield0.67%
Share Statistics
EPS (TTM)16.31
Shares Outstanding13,649,739
10 Day Avg. Volume12,508
30 Day Avg. Volume17,306
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)5.02
Price to Sales (P/S)5.14
P/FCF Ratio-229.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF342.00Price Target Upside11.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)13.51
Revenue Forecast (FY)CHF710.34M
Bulls Say, Bears Say
Bulls Say
High-margin Delivery SystemsThe core Delivery Systems business is large (>80% of group) and grew 20% to CHF 601m while delivering a 33% EBIT margin. Durable high margins on recurring device production and aftermarket consumables support reinvestment, scalability and resilience to cyclic demand swings.
Large, Convertible Project PipelineA record 44 deals and ~260 total programs with a ~70% historical hit rate provide multi-year visibility into future commercial launches and recurring manufacturing revenue. A deep, diversified pipeline reduces customer concentration risk and underpins sustainable top-line growth if conversion rates hold.
Strong Operating Cash Generation & Capital EfficiencyRobust operating cash flow (above CHF 300m), a healthy equity base and net debt/EBITDA near 0.8 alongside ~20% ROCE reflect efficient use of capital. This financial strength supports funding growth investments, selective buybacks and strategic projects while preserving financial flexibility.
Bears Say
Persistent Negative Free Cash FlowDespite strong operating cash, free cash flow has been negative across recent years, reflecting heavy capex and/or working‑capital consumption. Persistent FCF deficits constrain reinvestment flexibility, raise funding needs and increase reliance on external financing or share buybacks tradeoffs over the medium term.
Recent Revenue DeclineA 7.2% revenue decline in the latest year undermines recent growth momentum and raises execution risk. If sustained, top‑line contraction can erode operating leverage, pressure future margin targets and complicate attainment of mid‑term sales objectives absent successful conversion of the pipeline.
Large Capex, Ramp‑up And Stranded CostsMajor capacity expansions and site moves entail ramp‑up, stranded costs and multi‑year paybacks. Elevated growth capex (~CHF 1.3bn) increases execution risk and short‑term margin pressure; customer co‑financing mitigates but may not fully offset timing mismatches or regional competitive exposures.
YPSN FAQ
What was Ypsomed Holding AG’s price range in the past 12 months?
Ypsomed Holding AG lowest stock price was CHF260.50 and its highest was CHF441.50 in the past 12 months.
What is Ypsomed Holding AG’s market cap?
Ypsomed Holding AG’s market cap is CHF4.92B.
When is Ypsomed Holding AG’s upcoming earnings report date?
Ypsomed Holding AG’s upcoming earnings report date is Nov 18, 2026 which is in 137 days.
How were Ypsomed Holding AG’s earnings last quarter?
Ypsomed Holding AG released its earnings results on May 20, 2026. The company reported CHF6.11 earnings per share for the quarter, beating the consensus estimate of CHF6 by CHF0.11.
Is Ypsomed Holding AG overvalued?
According to Wall Street analysts Ypsomed Holding AG’s price is currently Undervalued.
Does Ypsomed Holding AG pay dividends?
Ypsomed Holding AG pays a Annually dividend of CHF4.4 which represents an annual dividend yield of 0.67%. See more information on Ypsomed Holding AG dividends here
What is Ypsomed Holding AG’s EPS estimate?
Ypsomed Holding AG’s EPS estimate is 5.25.
How many shares outstanding does Ypsomed Holding AG have?
Ypsomed Holding AG has 13,649,739 shares outstanding.
What happened to Ypsomed Holding AG’s price movement after its last earnings report?
Ypsomed Holding AG reported an EPS of CHF6.11 in its last earnings report, beating expectations of CHF6. Following the earnings report the stock price went up 9.33%.
Which hedge fund is a major shareholder of Ypsomed Holding AG?
Currently, no hedge funds are holding shares in CH:YPSN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
YPSN Stock 12 Month Forecast
Average Price Target
CHF342.00
▲(11.22% Upside)
Technical Analysis
Options Prices
Currently, No data available
---